We use Google Analytics to see which pages are read and how the site is used, so we know what to improve. This only runs if you accept. See our privacy notice for details.

Dáil

Written answer

Medicinal Products

Summary

The Minister referred questions on funding lupus biological drugs and two applications to the HSE, which decides medicine pricing and reimbursement.

3331. Deputy Pádraig Rice asked the Minister for Health if there are any plans to fund biological drugs for the treatment of lupus; the status of two applications (details supplied); and if she will make a statement on the matter. [55812/26]

Comment on this

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Comment on this